Deutsche Bank’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,086
Closed -$113K 5036
2016
Q3
$113K Buy
4,086
+252
+7% +$6.66K ﹤0.01% 3905
2016
Q2
$93K Buy
3,834
+3,027
+375% +$85.9K ﹤0.01% 4148
2016
Q1
$27K Buy
807
+475
+143% +$15K ﹤0.01% 4546
2015
Q4
$9K Buy
+332
New +$11.2K ﹤0.01% 4941
2015
Q2
Sell
-157
Closed -$6K 5429
2015
Q1
$6K Buy
+157
New +$5.64K ﹤0.01% 4877

Other funds holding PGEN

Deutsche Bank's PGEN Position: Q2 2026 in Review

Deutsche Bank increased its Precigen (PGEN) stake by 31% in Q2 2026, buying an estimated $206K and bringing the position to 200,248 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Deutsche Bank first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. The position peaked at $15.5M in Q3 2018. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Deutsche Bank held 200,248 shares of Precigen worth $1.14M as of Q2 2026.
  • Deutsche Bank bought 47,602 Precigen shares in Q2 2026, an estimated $206K.
  • Precigen made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2276 holding.
  • Deutsche Bank first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Precigen position peaked at $15.5M in Q3 2018.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.